Literature DB >> 2907064

[Primary prevention of hemorrhage of esophageal varices by beta-blockade--generally indicated?].

A Sieg1, B Kommerell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907064     DOI: 10.1007/BF01711928

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  18 in total

1.  A controlled study of the prophylactic portacaval shunt. A final report.

Authors:  R H Resnick; T C Chalmers; A M Ishihara; A J Garceau; A D Callow; E M Schimmel; E T O'Hara
Journal:  Ann Intern Med       Date:  1969-04       Impact factor: 25.391

2.  A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation.

Authors:  F C Jackson; E B Perrin; A G Smith; A E Dagradi; H M Nadal
Journal:  Am J Surg       Date:  1968-01       Impact factor: 2.565

3.  Pitfalls in studies of prophylactic therapy for variceal bleeding in cirrhotics.

Authors:  A K Burroughs; F D'Heygere; N McIntyre
Journal:  Hepatology       Date:  1986 Nov-Dec       Impact factor: 17.425

4.  A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report.

Authors:  D Lebrec; T Poynard; J Bernuau; E Bercoff; O Nouel; J P Capron; R Poupon; M Bouvry; B Rueff; J P Benhamou
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

5.  Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices.

Authors:  J P Pascal; P Cales
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

6.  Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial.

Authors:  A Gatta; C Merkel; D Sacerdoti; M Bolognesi; L Caregaro; R Zuin; P Angeli; A Ruol
Journal:  Digestion       Date:  1987       Impact factor: 3.216

7.  Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study.

Authors:  G Idéo; G Bellati; E Fesce; D Grimoldi
Journal:  Hepatology       Date:  1988 Jan-Feb       Impact factor: 17.425

8.  Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis.

Authors:  A K Burroughs; W J Jenkins; S Sherlock; A Dunk; R P Walt; T O Osuafor; S Mackie; R Dick
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

9.  Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study.

Authors:  L Witzel; E Wolbergs; H Merki
Journal:  Lancet       Date:  1985-04-06       Impact factor: 79.321

10.  Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial.

Authors:  K J Paquet
Journal:  Endoscopy       Date:  1982-01       Impact factor: 10.093

View more
  1 in total

Review 1.  Modern management of oesophageal varices.

Authors:  P J Gow; R W Chapman
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.